Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768739 · ClinicalTrials.gov registry record
Dysphagia and VFMI in Cardiac Patients
A clinical trial of Cardiac Disease, sponsored by University of Florida.
- Completed
- Registry status
- 207
- Enrollment target
- 3
- Study locations
NCT03768739: Completed study of Cardiac Disease, sponsored by University of Florida.
NCT03768739 is a study of Cardiac Disease that has completed, run by University of Florida. The registered enrollment target is 207 participants, below the 814-participant average among 24 other Cardiac Disease trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03768739, a study of Cardiac Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
- 3
- Study locations
Study Summary
The proposed study seeks to determine the incidence of dysphagia and vocal fold mobility impairment (VFMI) in individuals undergoing cardiothoracic surgical procedures. It also seeks to determine the impact of postoperative swallowing impairment on health-related outcomes.
Primary Outcome
This scale is a validated measure used by trained blinded clinicians to assign ratings of safety to swallowing bolus trials. The development and use of an 8-point, equal-appearing interval scale (8 being best; 1 being worst) to describe penetration and aspiration events are described. Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled.
Conditions Studied
Interventions
- PROCEDURE Fiberoptic Endoscopic Evaluation of Swallowing
Study Locations (3)
Florida
- Cardiovascular Clinic at UF Health UF - Gainesville
- UF Health at the University of Florida - Gainesville
- Thoracic and Cardiovasscular Surgery at UF Health - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2019-02-03 |
| Est. Completion | 2020-09-02 |
What the finished NCT03768739 record still lists
NCT03768739 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 814-participant average among 24 other Cardiac Disease trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Fiberoptic Endoscopic Evaluation of Swallowing is the first listed.
NCT03768739 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03768739 about?
NCT03768739 is a clinical study titled "Dysphagia and VFMI in Cardiac Patients". The proposed study seeks to determine the incidence of dysphagia and vocal fold mobility impairment (VFMI) in individuals undergoing cardiothoracic surgical procedures. It also seeks to determine the impact of postoperative swallowing impairment on health-related outcomes.
What is the current status of trial NCT03768739?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2019-02-03. Estimated completion is 2020-09-02.
What conditions does trial NCT03768739 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT03768739?
The interventions under investigation include: Fiberoptic Endoscopic Evaluation of Swallowing (PROCEDURE).
Who is sponsoring clinical trial NCT03768739?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03768739 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03768739's enrollment target sits among peer trials
207 11th of 24 higher than 14 of 24 other Cardiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI